Cancer Treatment (Oncology) · Kota Kinabalu, Malaysia
Breast cancer treatment cost in Kota Kinabalu
Treatments from
—
Options priced
0 of 13
How we collect & verify prices
In plain words · A tumor that starts in breast tissue — highly treatable when found early; treatment usually combines surgery with drug or radiation therapy.
Also known as: breast tumorbreast carcinoma
- MCI Index
- 23
- B pi
- Clinics
- 2
- in Kota Kinabalu
- Specialists
- 7
- who treat this
Top hospital for this in Kota Kinabalu · Newsweek #32 in Malaysia
#32 Queen Elizabeth Hospital 3.1★ MSQH
Queen Elizabeth Hospital (Hospital Queen Elizabeth) is Sabah's principal public tertiary referral hospital, run by the Ministry of Health Malaysia across two campuses in Kota Kinabalu: QEH1 at Kepayan (open since 1957) and QEH2 at Damai (opened 2009), which was rebranded in 2024 as the Sabah National Heart Centre (Pusat Jantung Negara Sabah) — Malaysia's second dedicated cardiac-treatment facility after the National Heart Institute (IJN) in Kuala Lumpur. Both campuses are listed in MSQH's Sabah public-hospital accreditation registry, with roughly 1,179 combined licensed beds (779 at QEH1, 400 at QEH2).
What treatment costs at each stage
Modeled previewStaging system: TNM (AJCC), commonly grouped as stage 0–IV. Stage is set by tumor size, nodes and spread — it decides which treatment anchors your cost, which is why condition prices span so widely.
- Stage 0 (in situ) Surgery, often with radiation Not yet priced
- Stage I–II (early) Surgery ± radiation; systemic therapy per case Not yet priced
- Stage III (locally advanced) Systemic therapy + surgery + radiation Not yet priced
- Stage IV (metastatic) Ongoing systemic therapy (hormonal, targeted, chemo) Not yet priced
The stage→treatment map is a modeled framework from public clinical taxonomy; prices are this registry's own rows for mapped treatments — empty means we haven't priced it, never a guess. Your stage and pathway are the specialist's call.
What diagnosis costs in Kota Kinabalu
Not yet sourcedYour first spend is the work-up, not the treatment — the typical items, priced from this registry where we hold them.
- 1 Specialist consultation Not yet priced
- 2 Imaging — mammogram Not yet priced
- 3 Image-guided biopsy Not yet priced
- 4 Pathology review Not yet priced
- 5 Staging imaging (CT / PET / MRI) Not yet priced
Consultation fees from our specialist registry; procedure prices from this condition's mapped diagnostics. Unverified prices are labeled on their own pages.
Breast cancer in other cities
ImportedThe same care market across the registry — cheapest entry first. Cheapest ≠ best: the MCI column grades each market as its data lands.
- Public-system wait at home (UK)NHS England referral-to-treatment statistics, Apr 2026 · Canada (CIHI) next 11.9-week median
- Recruiting breast cancer trials in MalaysiaClinicalTrials.gov — recruiting studies with a Malaysia site Not yet sourced
- JCI-accredited organizations in MalaysiaJCI public directory, country-wide (all specialties) Not yet sourced
Cheapest entry price per city with the size of its priced treatment menu and specialist density — countable signals only, "—" is never guessed.
Hospitals & clinics in Kota Kinabalu
Best firstThe best hospitals first — Newsweek World's Best national top 10 lead, then our connected-chain grade. Re-rank by rating or reviews.
- 74 Grade
- 67 Grade
Who gets breast cancer
VerifiedScale of the condition from the global cancer registry — context for why this care market exists.
New cases
2.3M
worldwide in 2022 — the most common cancer in women · IARC GLOBOCAN 2022
Deaths
666,000
worldwide in 2022 · IARC GLOBOCAN 2022
Share of cancers in women
23.8%
of all new cancer cases in women, 2022 · IARC GLOBOCAN 2022
Second opinion first — before you commit
Not yet sourcedHaving your existing diagnosis re-read here is the cheapest way to test a hospital's quality before booking anything. Prices land per hospital with sources — never estimated.
- Remote records review — written second opinion your existing scans, pathology and reports, reviewed without flying Not yet priced
- Video consultation with a specialist live case discussion after the review Not yet priced
- In-person specialist consultation reference price if you're already here Not yet priced
A second opinion changes the plan often enough that specialists expect to be asked for one — it's a normal request, not an insult. Remote-review prices are being collected per hospital.
The care pathway
Modeled previewHow the treatment decision is typically made for this condition — your specialist confirms the path for your case.
- 1
See the right specialist
Care for breast cancer starts with a specialist, who confirms the diagnosis and plans the next steps.
- 2
Diagnosis & tests
The diagnosis is confirmed with Breast Cancer X-ray Screening (Mammogram), Stereotactic Breast Biopsy or Magnetic Resonance Imaging (MRI), which also show how far it has progressed (staging).
- 3
Treatment options
Options include Breast Reconstruction Surgery, Hormonal Therapy (Endocrine Therapy for breast, prostate, thyroid cancers), Hormonal Therapy for Breast Cancer, Reconstructive Surgery (e.g., breast prostheses), Mastectomy, Lumpectomy, Radiation Therapy, Chemotherapy, Targeted Therapy or Immunotherapy — weighed on outcome, downtime, risk and total cost. See the priced menu and decision factors below.
- 4
Treatment
The chosen treatment plan is carried out — every option below links to its own price page with a recovery timeline.
- 5
Follow-up & monitoring
Scheduled scans and check-ups confirm the result and catch any recurrence early; remote follow-up is common for international patients.
Framework pathway modeled by field — per-condition clinical pathways replace it as they're sourced.
Who you'll see — the care team
Modeled previewSpecialist types by pathway phase — never named individuals — with real consultation fees where we hold them. Each links to its own price page.
- Diagnosis Radiologist reads your imaging Fee not yet priced
- Diagnosis Pathologist confirms the diagnosis from the biopsy Fee not yet priced
- Decision & systemic treatment Oncologist stages the disease and owns the treatment plan Fee not yet priced
- Local treatment Radiation therapist plans and delivers radiotherapy Fee not yet priced
Fees are city-level consultation ranges from our specialist registry (imported, re-verified over time). Doctors are hospital attributes — you choose the provider on its hospital page, never a named individual here.
Choosing between the options
Modeled previewWhat actually decides between the treatments above — and the checklist an expert would put to the specialist.
Decision factors
- 1How advanced the condition is — stage or severity narrows the menu first
- 2Your goal: cure, control, symptom relief or appearance
- 3Downtime you can afford — the options below differ by weeks
- 4Total cost with travel and follow-up, not just the sticker price
- 5Tumor biology — some options only work for specific types
Ask the specialist
- 1Will my case be reviewed by a multidisciplinary tumor board?
- 2How many of this exact procedure did you perform last year?
- 3What is your complication and revision rate for it?
- 4What anesthesia will be used, and who administers it?
- 5Who manages my aftercare once I fly home, and how?
- 6What exactly is included in the quoted price — and what isn't?
A planning frame — suitability is always the specialist's call.
Malaysia for medical travel — safety, recourse & visa
Sourced Full Malaysia guide →What matters if it goes wrong, and what it takes to get there — country-level, verifiable guidance in one place.
- Visa
- Most Western nationalities (US, UK, EU, Australia) enter visa-free for 30–90 days for tourism or business; travel purely for treatment uses a medical visa.
- Medical / long-stay visa
- Malaysia issues a Medical Tourism e-Visa for treatment longer than the visa-free window, granted on an invitation letter from an MHTC-registered hospital via the immigration eVISA portal.
- Arrival
- Most travellers must complete the free Malaysia Digital Arrival Card (MDAC) online within 3 days before arrival.
- Currency
- Malaysian Ringgit (RM / MYR)
- Languages
- Malay and English are official; English is widely spoken and staff at international hospitals are English-speaking
- Traveller safety
- Generally safe
- Legal recourse
- Limited recourse — use a medical-travel insurer
- Insurance
- Medical-travel & complication cover widely available
- International patients
- Hospitals accustomed to international patients
General guidance from public sources — confirm current rules for your nationality. Verified against: Malaysia MyVISA (immigration eVISA — Medical) · Malaysia Healthcare Travel Council (MHTC).
Specialists & related conditions
DirectoryWho treats breast cancer, and nearby diagnoses in the same field.
Dots carry the lens colors — teal opens a specialist page, red another condition, both priced for Kota Kinabalu.
Data & sources
30% verified Methodology →How much of this page is verified data — every section carries a chip telling you where its numbers come from.
All 10 data fields — what's verified, imported or modeled Show more Hide
- Treatment prices· 0 of 13 options Not yet collected
- Cross-city comparison· 39 priced Imported
- Provider directory· 2 clinics Imported
- Care pathway & decision factors· sourced per-condition ✓ Verified
- Stage → cost map· TNM (AJCC), commonly grouped as stage 0–IV Modeled
- Diagnosis price basket· 0 of 5 priced Not yet collected
- Prevalence & guidelines· IARC GLOBOCAN 2022 ✓ Verified
- Second opinion & fly-or-stay math Not yet collected
- Outcome benchmarks· slots ready — feed the Index Not yet collected
- Visa & travel guidance ✓ Verified
Every field is tagged by source state. "Verified" = sourced and checked; "Imported" = real data pending re-verification; "Modeled" = deterministic placeholder for this preview; "Not yet collected" = on our roadmap. Confidence feeds the Medical Travel Cost Index.
Clinical practice guidelines — who sets the treatment standard
- NCCN (US) — Clinical Practice Guidelines in Oncology — Breast Cancer · updated annually Reference
- ESMO (Europe) — Clinical Practice Guidelines — early & metastatic breast cancer Reference
- NICE (UK) — NG101 — Early and locally advanced breast cancer Reference
Cited as the bodies that define the standard of care — we never summarize guidelines into medical advice.